fluphenazine depot has been researched along with lithium carbonate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sachdev, PS | 1 |
Choras, PT; Cole, JO; Fulwiler, CE; Pope, HG | 1 |
Singh, SV | 1 |
Bartone, P; Carter, M; Cooley, S; DiBarry, AL; Hammill, K; Hogarty, GE; McEvoy, JP; Munetz, MR; Perel, J; Ulrich, RF | 1 |
Charles, J; Miller, G; Ng, A | 1 |
1 trial(s) available for fluphenazine depot and lithium carbonate
Article | Year |
---|---|
Pharmacotherapy of impaired affect in recovering schizophrenic patients.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Basal Ganglia Diseases; Benztropine; Depressive Disorder; Desipramine; Diagnosis, Differential; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Glycopyrrolate; Humans; Lithium Carbonate; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sex Factors | 1995 |
4 other study(ies) available for fluphenazine depot and lithium carbonate
Article | Year |
---|---|
Lithium potentiation of neuroleptic-related extrapyramidal side effects.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Lithium Carbonate; Time Factors | 1986 |
Apparent neuroleptic malignant syndrome with clozapine and lithium.
Topics: Adult; Bipolar Disorder; Clozapine; Dibenzazepines; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Lithium Carbonate; Male; Neuroleptic Malignant Syndrome | 1986 |
Lithium carbonate/fluphenazine decanoate producing irreversible brain damage.
Topics: Adult; Bipolar Disorder; Brain; Brain Diseases; Drug Synergism; Dysarthria; Female; Fluphenazine; Humans; Lithium; Lithium Carbonate; Speech Disorders | 1982 |
Management of psychosis in Australian general practice.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazepines; Directive Counseling; Female; Fluphenazine; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Psychotic Disorders; Referral and Consultation; Sex Factors | 2006 |